supported by Shenzhen Sanming Project(No.SZSM201612051)。
Gastric cancer,with high morbidity and mortality rates,is one of the most heterogeneous tumors.Radical gastrectomy and postoperative chemotherapy are the standard treatments.However,the safety and efficacy of neoadjuv...
supported by the grants of the Hi-Tech Research and Development Program of China (Grant No.2006AA02Z4B4);the National Key Projects of Research and Development of China (Grant No.2016YFC0904600)
Objective:The radioprotective effects of amifostine remain uncertain in patients with nasopharyngeal carcinoma(NPC),and adverse effects and cost limit generalization of its classical everyday regimen.This phase II ...